Efficacy, Safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
October 2023
in “
Clinical, cosmetic and investigational dermatology
”
Studysummary In this study, traditional treatment for pediatric alopecia areata was highly effective, with all patients achieving full hair regrowth. Tofacitinib and microneedling were less effective but are viable options for severe cases, while adverse effects were mild across all treatments.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In a retrospective cohort study of 24 pediatric patients with alopecia areata (AA), three treatment strategies were evaluated for efficacy, safety, and pharmacoeconomics. The traditional treatment group had a 100% (12/12) success rate in achieving complete hair regrowth (SALT100), while in the tofacitinib group, 40% (2/5) reached at least 50% hair regrowth (SALT50), and another 40% (2/5) achieved complete regrowth (SALT100). In the microneedling (MN) group, 42.86% (3/7) were non-responders, but another 42.86% (3/7) achieved complete regrowth (SALT100). All treatments had mild adverse effects, with no treatment discontinuations due to these effects. The study concluded that traditional treatment should be the first-line approach for newly diagnosed or treatment-naive pediatric AA patients, while tofacitinib and microneedling could be considered for severe, long-duration, or refractory cases, with the caveat that MN is more time-intensive and expensive.
